QQ客服 官方微博 反馈留言

	Enhanced circulating ILC2s and MDSCs may contribute to ensure maintenance of Th2 predominant in patients with lung cancer
	Wu, Yumin[1]; Yan, Yulan[2]; Su, Zhaoliang[3]; Bie, Qingli[4]; Chen, Xiaobo[5]; Barnie, Prince Amoah[6]; Guo, Qi[7]; Wang, Shengjun[8]; Xu, Huaxi[9]
刊名	MOLECULAR MEDICINE REPORTS
	2017
卷号	15期号:6页码:4374-4381
关键词	group 2 innate lymphoid cells myeloid-derived suppressor cells type 2 T helper cells lung cancer
ISSN号	1791-2997
DOI	http://dx.doi.org/10.3892/mmr.2017.6537
URL标识	查看原文
收录类别	SCI(E) ; PUBMED
WOS记录号	WOS:000401071600127
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5353597
专题	江苏大学
作者单位	1.[1]Jiangsu Univ, Sch Med, Dept Immunol, 301 Xuefu Rd, Zhenjiang 212013, Jiangsu, Peoples R China. 2.[2]Jiangsu Univ, Affiliated Peoples Hosp, Dept Pulmonol, Zhenjiang 212001, Jiangsu, Peoples R China. 3.[3]Jiangsu Univ, Sch Med, Dept Immunol, 301 Xuefu Rd, Zhenjiang 212013, Jiangsu, Peoples R China. 4.[4]Jiangsu Univ, Sch Med, Dept Immunol, 301 Xuefu Rd, Zhenjiang 212013, Jiangsu, Peoples R China. 5.[5]Jiangsu Univ, Sch Med, Dept Immunol, 301 Xuefu Rd, Zhenjiang 212013, Jiangsu, Peoples R China. 6.[6]Jiangsu Univ, Sch Med, Dept Immunol, 301 Xuefu Rd, Zhenjiang 212013, Jiangsu, Peoples R China. 7.Univ Cape Coast, Sch Biol Sci, Dept Biomed & Forens Sci, Cape Coast 999064, Ghana. 8.[7]Jiangsu Univ, Sch Med, Dept Immunol, 301 Xuefu Rd, Zhenjiang 212013, Jiangsu, Peoples R China. 9.[8]Jiangsu Univ, Sch Med, Dept Immunol, 301 Xuefu Rd, Zhenjiang 212013, Jiangsu, Peoples R China. 10.[9]Jiangsu Univ, Sch Med, Dept Immunol, 301 Xuefu Rd, Zhenjiang 212013, Jiangsu, Peoples R China.
推荐引用方式 GB/T 7714	Wu, Yumin[1],Yan, Yulan[2],Su, Zhaoliang[3],et al. Enhanced circulating ILC2s and MDSCs may contribute to ensure maintenance of Th2 predominant in patients with lung cancer[J]. MOLECULAR MEDICINE REPORTS,2017,15(6):4374-4381.
APA	Wu, Yumin[1].,Yan, Yulan[2].,Su, Zhaoliang[3].,Bie, Qingli[4].,Chen, Xiaobo[5].,...&Xu, Huaxi[9].(2017).Enhanced circulating ILC2s and MDSCs may contribute to ensure maintenance of Th2 predominant in patients with lung cancer.MOLECULAR MEDICINE REPORTS,15(6),4374-4381.
MLA	Wu, Yumin[1],et al."Enhanced circulating ILC2s and MDSCs may contribute to ensure maintenance of Th2 predominant in patients with lung cancer".MOLECULAR MEDICINE REPORTS 15.6(2017):4374-4381.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。